| Cash Flow | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Net cash used in financing activities | -2,184,100 | -1,029,600 | -680,400 | -1,103,600 |
| Effect of changes in exchange rates on cash | 83,600 | 87,700 | 30,500 | 4,700 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 375,600 | 409,800 | 113,200 | -5,124,200 |
| Cash and cash equivalents at beginning of period | 4,572,200 | - | - | - |
| Cash and cash equivalents at end of period | 4,947,800 | - | - | - |
VERTEX PHARMACEUTICALS INC MA (VRTX)
VERTEX PHARMACEUTICALS INC MA (VRTX)